TY - JOUR
T1 - Esophageal mucosal integrity improves after laparoscopic antireflux surgery in children with gastroesophageal reflux disease
AU - Mauritz, Femke A.
AU - Rinsma, Nicolaas F.
AU - van Heurn, Ernest L. W.
AU - Sloots, Cornelius E. J.
AU - Siersema, Peter D.
AU - Houwen, Roderick H. J.
AU - van der Zee, David C.
AU - Masclee, Ad A. M.
AU - Conchillo, Jose M.
AU - van Herwaarden-Lindeboom, Maud Y. A.
PY - 2017/7
Y1 - 2017/7
N2 - Background Esophageal intraluminal baseline impedance reflects the conductivity of the esophageal mucosa and may be an instrument for in vivo evaluation of mucosal integrity in children with gastroesophageal reflux disease (GERD). Laparoscopic antireflux surgery (LARS) is a well-established treatment option for children with proton pump inhibitory (PPI) therapy resistant GERD. The effect of LARS in children on baseline impedance has not been studied in detail. The aim of this study was to evaluate the effect of LARS on baseline impedance in children with GERD.Methods This is a prospective, multicenter, nationwide cohort study (Dutch national trial registry: NTR2934) including 25 patients [12 males, median age 6 (range 2-18) years] with PPI-resistant GERD scheduled to undergo LARS. Twenty-four hour multichannel intraluminal impedance pH monitoring (MII-pH monitoring) was performed before and 3 months after LARS. Baseline impedance was evaluated during consecutive 2-h intervals in the 24-h tracings.Results LARS reduced acid exposure time from 8.5 % (6.0-16.2 %) to 0.8 % (0.2-2.8 %), p <0.001. Distal baseline impedance increased after LARS from 2445 Omega (1147-3277 Omega) to 3792 Omega (3087-4700 Omega), p <0.001. Preoperative baseline impedance strongly correlated with acid exposure time (r -0.76, p <0.001); however, no association between symptomatic outcome and baseline impedance was identified.Conclusions LARS significantly increased baseline impedance likely reflecting recovery of mucosal integrity. As the change in baseline impedance was not associated with the clinical outcome of LARS, other factors besides mucosal integrity may contribute to symptom perception in children with GERD.
AB - Background Esophageal intraluminal baseline impedance reflects the conductivity of the esophageal mucosa and may be an instrument for in vivo evaluation of mucosal integrity in children with gastroesophageal reflux disease (GERD). Laparoscopic antireflux surgery (LARS) is a well-established treatment option for children with proton pump inhibitory (PPI) therapy resistant GERD. The effect of LARS in children on baseline impedance has not been studied in detail. The aim of this study was to evaluate the effect of LARS on baseline impedance in children with GERD.Methods This is a prospective, multicenter, nationwide cohort study (Dutch national trial registry: NTR2934) including 25 patients [12 males, median age 6 (range 2-18) years] with PPI-resistant GERD scheduled to undergo LARS. Twenty-four hour multichannel intraluminal impedance pH monitoring (MII-pH monitoring) was performed before and 3 months after LARS. Baseline impedance was evaluated during consecutive 2-h intervals in the 24-h tracings.Results LARS reduced acid exposure time from 8.5 % (6.0-16.2 %) to 0.8 % (0.2-2.8 %), p <0.001. Distal baseline impedance increased after LARS from 2445 Omega (1147-3277 Omega) to 3792 Omega (3087-4700 Omega), p <0.001. Preoperative baseline impedance strongly correlated with acid exposure time (r -0.76, p <0.001); however, no association between symptomatic outcome and baseline impedance was identified.Conclusions LARS significantly increased baseline impedance likely reflecting recovery of mucosal integrity. As the change in baseline impedance was not associated with the clinical outcome of LARS, other factors besides mucosal integrity may contribute to symptom perception in children with GERD.
KW - Gastroesophageal reflux disease
KW - Laparoscopic fundoplication
KW - Baseline impedance
KW - Pediatrics
KW - BASE-LINE IMPEDANCE
KW - MULTICHANNEL INTRALUMINAL IMPEDANCE
KW - PARTIAL FUNDOPLICATION
KW - ACID EXPOSURE
KW - GERD PATIENTS
KW - GAS REFLUX
KW - INFANTS
KW - HEARTBURN
KW - PATTERNS
KW - AGE
U2 - 10.1007/s00464-016-5304-0
DO - 10.1007/s00464-016-5304-0
M3 - Article
C2 - 27804042
SN - 0930-2794
VL - 31
SP - 2910
EP - 2917
JO - Surgical endoscopy and other interventional techniques
JF - Surgical endoscopy and other interventional techniques
IS - 7
ER -